| Dr Debra Ann Carson, DO | |
|
120 Hospital Dr Ste 225, Lebanon, MO 65536-9254 | |
| (417) 533-6710 | |
| Not Available |
| Full Name | Dr Debra Ann Carson |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 22 Years |
| Location | 120 Hospital Dr Ste 225, Lebanon, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043410392 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Lebanon | Lebanon, MO | Hospital |
| Mercy Hospital Springfield | Springfield, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Springfield Communities | 7416865845 | 922 |
News Archive
Pharmaceutical research and biotechnology companies in New Jersey, California, New York and North Carolina are responsible for 192 of the 313 medicines in development today to treat mental illnesses, a new survey shows.
A new study into the genetics underlying restless legs syndrome has identified 13 previously-unknown genetic risk variants, while helping inform potential new treatment options for the condition.
Isis Pharmaceuticals, Inc. today announced its financial results for the quarter ended June 30, 2010. The Company finished the second quarter of 2010 with a pro forma net operating loss (NOL) of $15.5 million and $17.1 million for the three and six months ended June 30, 2010, respectively, compared to a pro forma net operating loss of $1.3 million and pro forma net operating income of $798,000 for the same periods of 2009.
Today's early morning highlights from the major news organizations include artilces about a new GOP tax plan that includes a Medicare pay fix for doctors and President Obama's support of a decision to keep the "Morning After Pill" from minors.
› Verified 2 days ago
| Entity Name | Mercy Clinic Springfield Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245277631 PECOS PAC ID: 7416865845 Enrollment ID: O20031104000060 |
News Archive
Pharmaceutical research and biotechnology companies in New Jersey, California, New York and North Carolina are responsible for 192 of the 313 medicines in development today to treat mental illnesses, a new survey shows.
A new study into the genetics underlying restless legs syndrome has identified 13 previously-unknown genetic risk variants, while helping inform potential new treatment options for the condition.
Isis Pharmaceuticals, Inc. today announced its financial results for the quarter ended June 30, 2010. The Company finished the second quarter of 2010 with a pro forma net operating loss (NOL) of $15.5 million and $17.1 million for the three and six months ended June 30, 2010, respectively, compared to a pro forma net operating loss of $1.3 million and pro forma net operating income of $798,000 for the same periods of 2009.
Today's early morning highlights from the major news organizations include artilces about a new GOP tax plan that includes a Medicare pay fix for doctors and President Obama's support of a decision to keep the "Morning After Pill" from minors.
› Verified 2 days ago
| Entity Name | Mercy Clinic Springfield Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972771657 PECOS PAC ID: 7416865845 Enrollment ID: O20031218000354 |
News Archive
Pharmaceutical research and biotechnology companies in New Jersey, California, New York and North Carolina are responsible for 192 of the 313 medicines in development today to treat mental illnesses, a new survey shows.
A new study into the genetics underlying restless legs syndrome has identified 13 previously-unknown genetic risk variants, while helping inform potential new treatment options for the condition.
Isis Pharmaceuticals, Inc. today announced its financial results for the quarter ended June 30, 2010. The Company finished the second quarter of 2010 with a pro forma net operating loss (NOL) of $15.5 million and $17.1 million for the three and six months ended June 30, 2010, respectively, compared to a pro forma net operating loss of $1.3 million and pro forma net operating income of $798,000 for the same periods of 2009.
Today's early morning highlights from the major news organizations include artilces about a new GOP tax plan that includes a Medicare pay fix for doctors and President Obama's support of a decision to keep the "Morning After Pill" from minors.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Debra Ann Carson, DO 120 Hospital Dr Ste 225, Lebanon, MO 65536-9254 Ph: (417) 533-6710 | Dr Debra Ann Carson, DO 120 Hospital Dr Ste 225, Lebanon, MO 65536-9254 Ph: (417) 533-6710 |
News Archive
Pharmaceutical research and biotechnology companies in New Jersey, California, New York and North Carolina are responsible for 192 of the 313 medicines in development today to treat mental illnesses, a new survey shows.
A new study into the genetics underlying restless legs syndrome has identified 13 previously-unknown genetic risk variants, while helping inform potential new treatment options for the condition.
Isis Pharmaceuticals, Inc. today announced its financial results for the quarter ended June 30, 2010. The Company finished the second quarter of 2010 with a pro forma net operating loss (NOL) of $15.5 million and $17.1 million for the three and six months ended June 30, 2010, respectively, compared to a pro forma net operating loss of $1.3 million and pro forma net operating income of $798,000 for the same periods of 2009.
Today's early morning highlights from the major news organizations include artilces about a new GOP tax plan that includes a Medicare pay fix for doctors and President Obama's support of a decision to keep the "Morning After Pill" from minors.
› Verified 2 days ago
Denis E Percell, D.O. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 120 Hospital Dr, Suite 225, Lebanon, MO 65536 Phone: 417-533-6710 Fax: 417-533-6719 | |
Dr. Donald E. Hicks, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 120 Hospital Dr, Suite 225, Lebanon, MO 65536 Phone: 417-533-6710 Fax: 417-533-6719 | |
Dr. William Frank Williams, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 120 Hospital Dr, Suite 225, Lebanon, MO 65536 Phone: 417-533-6710 Fax: 417-533-6719 |